Halyard Health, Inc. (HYH) Forms $47.81 Double Top; Antofagasta plc (LON:ANTO) Had 7 Bulls

Among 29 analysts covering Antofagasta PLC (LON:ANTO), 7 have Buy rating, 14 Sell and 8 Hold. Therefore 24% are positive. Antofagasta PLC had 355 analyst reports since July 23, 2015 according to SRatingsIntel. BNP Paribas maintained Antofagasta plc (LON:ANTO) on Wednesday, February 3 with “Outperform” rating. Investec maintained it with “Sell” rating and GBX 298 target in Tuesday, November 17 report. The firm has “Sell” rating by Goldman Sachs given on Friday, October 9. The rating was maintained by Canaccord Genuity on Wednesday, February 1 with “Hold”. The rating was maintained by Credit Suisse on Tuesday, October 13 with “Underperform”. The stock of Antofagasta plc (LON:ANTO) has “Hold” rating given on Tuesday, August 25 by Canaccord Genuity. The stock of Antofagasta plc (LON:ANTO) earned “Hold” rating by Deutsche Bank on Wednesday, July 13. The stock has “Buy” rating by Haitong Securities on Thursday, June 30. The firm has “Underperform” rating by Credit Suisse given on Thursday, May 12. Berenberg maintained the stock with “Sell” rating in Wednesday, November 30 report. See Antofagasta plc (LON:ANTO) latest ratings:

18/12/2017 Broker: Jefferies Rating: Buy Maintain
27/11/2017 Broker: Liberum Capital Rating: Sell Old Target: GBX 420.00 New Target: GBX 535.00 Maintain
24/11/2017 Broker: Peel Hunt Rating: Hold Old Target: GBX 1000.00 New Target: GBX 1010.00 Maintain
21/11/2017 Broker: Peel Hunt Rating: Hold Old Target: GBX 1000.00 New Target: GBX 1000.00 Maintain
15/11/2017 Broker: Credit Suisse Rating: Underperform Old Target: GBX 690.00 New Target: GBX 780.00 Maintain
26/10/2017 Broker: Deutsche Bank Rating: Sell Old Target: GBX 800.00 New Target: GBX 800.00 Maintain
26/10/2017 Broker: Berenberg Rating: Sell Old Target: GBX 760.00 New Target: GBX 750.00 Maintain
26/10/2017 Broker: JP Morgan Rating: Underweight Old Target: GBX 670.00 New Target: GBX 660.00 Maintain
26/10/2017 Broker: Macquarie Research Rating: Neutral Old Target: GBX 940.00 New Target: GBX 920.00 Maintain
25/10/2017 Broker: Liberum Capital Rating: Sell Old Target: GBX 420.00 New Target: GBX 420.00 Maintain

Halyard Health, Inc. (HYH) formed double top with $50.20 target or 5.00% above today’s $47.81 share price. Halyard Health, Inc. (HYH) has $2.24 billion valuation. The stock increased 1.53% or $0.72 during the last trading session, reaching $47.81. About 173,572 shares traded. Halyard Health, Inc. (NYSE:HYH) has risen 28.46% since January 7, 2017 and is uptrending. It has outperformed by 11.76% the S&P500.

Analysts await Halyard Health, Inc. (NYSE:HYH) to report earnings on February, 26. They expect $0.50 earnings per share, 0.00% or $0.00 from last year’s $0.5 per share. HYH’s profit will be $23.42 million for 23.91 P/E if the $0.50 EPS becomes a reality. After $0.60 actual earnings per share reported by Halyard Health, Inc. for the previous quarter, Wall Street now forecasts -16.67% negative EPS growth.

Among 7 analysts covering Halyard Health Inc (NYSE:HYH), 3 have Buy rating, 1 Sell and 3 Hold. Therefore 43% are positive. Halyard Health Inc had 18 analyst reports since July 21, 2015 according to SRatingsIntel. The stock has “Buy” rating by Stifel Nicolaus on Wednesday, August 2. The firm earned “Buy” rating on Tuesday, June 14 by Stifel Nicolaus. The firm earned “Buy” rating on Wednesday, January 27 by Stifel Nicolaus. The firm earned “Buy” rating on Monday, September 18 by Stifel Nicolaus. The stock of Halyard Health, Inc. (NYSE:HYH) has “Buy” rating given on Friday, September 11 by Deutsche Bank. On Wednesday, December 2 the stock rating was initiated by Stifel Nicolaus with “Buy”. The stock has “Buy” rating by Deutsche Bank on Wednesday, August 10. On Tuesday, October 17 the stock rating was maintained by KeyBanc Capital Markets with “Hold”. The stock of Halyard Health, Inc. (NYSE:HYH) earned “Overweight” rating by Stephens on Thursday, August 3. The firm earned “Mkt Perform” rating on Friday, January 6 by JMP Securities.